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Visceraladiposityisariskfactor forcardiovasculardisorders,type2diabetesmellitus(T2D)andassociated
metabolic diseases. Sub-cutaneous fat is believed to be intrinsically different from visceral fat. To
understandmolecularmechanismsinvolvedinmetabolicadvantagesoffattransplantation,westudiedarat
model of diet-induced adiposity. Adipokine genes (Adiponectin, Leptin, Resistin and Visfatin) were
expressed at 10,000 to a million-fold lower in visceral fat depot as compared to peripheral (thigh/chest) fat
depots. Interestingly, autologous transplantation of visceral fat to subcutaneous sites resulted in increased
gene transcript abundance in the grafts by 3 weeks post-transplantation, indicating the impact of local
(residence) factors influencing epigenetic memory. We show here that active transcriptional state of
adipokine genes is linked with glucose mediated recruitment of enzymes that regulate histone methylation.
Adipose depots have ‘‘residence memory’’ and autologous transplantation of visceral fat to sub-cutaneous
sites offers metabolic advantage.
O
besity is now considered as a global health disorder since it is associated with low grade inflammation,
type2diabetesandadversemetabolicoutcomes
1.Morethan1.5billionadultsareoverweightworldwide
ofwhichfivehundred millionareestimatedtobeobese,largelyduetoconsumption ofhighenergyfood
containingsaturatedfatsandsugarscombinedwithreducedphysicalactivity.However,apartfromtheamountof
body fat, it is now well known that the distribution of fat is an important predictor of metabolic abnormalities
2,3.
The high prevalence of cardiovascular disease and type 2 diabetes in South Asians and Indians is associated with
accumulation of visceral fat
4. Adipose tissue is now recognized as an endocrine organ that secretes several
inflammatory and immune mediators or adipokines, including leptin, visfatin, resistin and adiponectin
5,6, which
play an important role in outcome of metabolic disease. Subcutaneous adipose tissue (SAT) is proposed as a
‘‘metabolic sink’’ for circulating non-esterified fatty acids and by increased clearance of triacylglycerol
from circulation
7. Therefore low subcutaneous thigh fat is associated with higher glucose and lipid levels
8.
Conversely high visceral adiposity is independently associated with insulin resistance
9,10, type 2 diabetes melli-
tus
11–13, cardiovascular disorders
14,15 and inflammatory disorders
16,17 through dysregulation of adipokine secre-
tion and free fatty acid toxicity. It is evident that visceral fat represents a physiologically important reservoir of
adipose tissue that is functionally distinct from the subcutaneous fatdepots. Infact, thereare now several lines of
evidencethatconvergetobelievethebeneficialeffectsofsubcutaneousfatonmetabolism.First,arecentstudyon
obese women demonstrates that women with a healthy metabolic profile had significantly lower visceral fat
volume and less insulin resistance than those with metabolic abnormalities
18. These observations support the
previous notion that subcutaneous fat depots have beneficial effects on insulin resistance
19,20 in overweight or
obese individuals. Secondly, these beneficial effects of subcutaneous fat depots are in line with the effects of
pioglitazone treatment, which improves insulin sensitivity despite increasing total body fat mass; mainly sub-
cutaneous fat
21.Thethird line ofevidence comes fromstudies intransgenic ob/obmice with forced expression of
adiponectin
22. Here, authors observed that transgenic animals, expressing Adiponectin, had better metabolic
profiles as compared to wild type ob/ob mice and this was associated with increase in adiposity, primarily due to
increases in sub-cutaneous fat depots
22,23. Lastly, transplantation of exogenous visceral fat to sub-cutaneous
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24 or transplantation of exogenous sub-cutaneous fat to donor
visceral region
3 has shown beneficial effects in reversing the meta-
bolic outcome by lowering insulin resistance in these mice. All of
these studies confirm the intrinsic differences in visceral and peri-
pheraladiposedepots
25.Duringpost-natallife,fatcellsareexposedto
extrinsic factors such as hormones, growth factors and supply of
nutrients, including high levels of local glucose concentrations
in visceral/gut region
26. Based on the idea that visceral fat has
deleterious effects on metabolism, surgical removal of visceral fat
was proposed to be a way forward in achieving lower visceral
adiposity. However, removal of visceral fat alone does not provide
metabolic advantages
27,28, possibly because visceral fat is highly
mobilized. Although fat transplantation involving donor and recipi-
ent mice has been carried out earlier
3,24, we raised the question: Does
autologous transplantation of visceral fat to sub-cutaneous region
offer metabolic advantage?
In the current study, we investigated this question by carrying out
autologous transplantation of visceral (intra-abdominal) fat to sub-
cutaneous (thigh/chest) sites and examined the effects of this fat
translocation on metabolic outcome at physiological and at mole-
cular level. Surprisingly, we find that translocation of visceral fat to
sub-cutaneous sites offers metabolic advantage, while mere removal
of equivalent visceral fat did not provide this advantage. We present
molecular analysis of epigenetic changes that occur after autologous
fat transplantation (translocation) and demonstrate that glucose
epigenetically regulates the expression of adipokines in visceral
and peripheral fat to confer this advantage to fat depots in
peripheral sites.
Figure 1 | Adipokine gene expression in fat depots. (A) Adipose tissue from different sites was snap frozen and collected for gene expression analysis
using TaqMan-based quantitative real-time PCR. (B) Expression of Adipoq (Adiponectin), Lep (Leptin), Retn (Resistin) and Nampt (Visfatin) were
significantlylowerinvisceraladiposetissue(redcircles)ascomparedtoadiposetissueobtainedfromother(peripheral)sites/depots.Geneexpressionfor
each animal is shown in the scatter plot (N59).
www.nature.com/scientificreports
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Body composition and adipokine expression analyses. Since
metabolic outcomes seen in human populations are difficult to be
reproduced in genetic knockout models, we studied a colony of
Wistar rats maintained on a high fat diet for 2 consecutive
generations (Supplementary figure 1). Hyperinsulinemic euglycemic
clamp studies demonstrate that F2 rats are insulin resistant as
compared to age and sex matched F0 controls (Supplementary
figure 1D). All studies discussed henceforth in this manuscript are
carried on 8 month old F2 animals. We measured gene transcript
levels of the adipokines; adiponectin (Adipoq), Leptin (Lep), Resistin
(Retn) and Visfatin (Nampt) by using TaqMan-based real-time
quantitative PCR (qPCR) in 8 different fat depots (Figure 1A). We
observesignificantdifferencesintheabundanceofgenetranscriptsfor
these 4 adipokines across all the fat depots (Figure 1B). Surprisingly,
the expression of the 4 adipokines (Adipoq, Lep, Retn, Nampt)i nt h e
visceral fat was 10,000 to a million-fold lower than that observed in
subcutaneous (thigh or chest) regions. This observation led us to plan
fat translocation studies so as to assess the fate of autologous
transplanted visceral fat in peripheral (subcutaneous) sites.
Autologous translocation of visceral fat to subcutaneous region.
Around 40% of visceral fat was surgically removed (Supplementary
figure 2) and 95% of this excised fat was transplanted sub-
cutaneously, either in the thigh region (Supplementary figure 2E)
or chest region (Supplementary figure 2G) of the same rat. No
incidence of graft rejection was recorded in any of the autologous
fat transplant surgeries carried out.
We then assessed the morphology of visceral and sub-cutaneous
fat on the day of transplant (Supplementary figure 3A,B) as well as 4
or 21 days after transplantation (Supplementary figure 3C,D). We
observethatadipose cells inthevisceralfatdepot aregenerallylarger
as compared to those in the thigh fat depot (Supplementary figure
3A,B). However, we observe that visceral fat showed changes in cell
size and appear similar to cells in the thigh adipose tissue during the
21daysoftranslocation (Supplementaryfigure3C,D).Next,wecon-
firmed that the excised visceral fat grafts were vascularized as evi-
denced by presence of vasculature (Supplementary figure 3E,F) and
analysis of CD31
1 endothelial cells in visceral fat grafts recovered
from thigh region (Supplementary figure 3G–J). We then assessed
gene transcript abundance for Adiponectin, Leptin, Resistin and
Visfatin (Figure 2) in visceral fat (day 0/day of transplant and day
21post-transplant),thighfatandvisceralfatgraftinthethigh(day21
post-transplant). Interestingly, we observe that after translocation to
sub-cutaneous sites, the expression profiles of the 4 adipokine genes
in the graft was similar to the expression profile of residual fat in the
thigh region. When visceral fat was translocated to the chest region,
we also observe similar increases in gene expression profile
(Supplementary figure 4). These data clearly indicate that the sub-
cutaneous niche can impart ‘‘residence memory’’ to grafted visceral
tissue leading to increase in the abundance of gene transcripts in the
visceral fat grafted in thigh (VT) or chest (VC) regions (Figure 2).
Increase in gene expression correlates with relaxed chromatin
conformation. Quantitative real time PCR is a very sensitive
technique that measures the abundance of gene transcripts at a
given time. However, this increase in adipokine gene transcripts
seen in visceral grafts following VT or VC translocation could be
either due to increase in rate of gene expression or decrease in rate of
transcript degradation. It is well known that an increase in rate of
gene expression is directly related to accessibility of the
transcriptional machinery to gene promoter regions. We therefore
carried out chromatin immunoprecipitation (ChIP) analysis using
histone methylation-specific antibodies that identify active (H3K4)
Figure 2 | Adipokine gene expression in Visceral fat depot matches expression levels in resident (thigh) depot following autologous transplantation.
Following 3 weeks after transplantation of visceral adipose tissue (V) to subcutaneous (thigh) region (T) the abundance of adipokine gene transcripts in
the transplanted (VT) tissue was estimated by TaqMan-based quantitative PCR. We observe that gene transcript abundance in the grafts (VT) was
significantlyhigherthanthatobservedonthedayoftransplantation(Visceral;V),andnotdifferentfromtheabundanceofgenetranscriptdetectedinthe
resident thigh fat.
www.nature.com/scientificreports
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observe that all the 4 adipokine gene promoter regions in the thigh
and chest (resident) fat tissue show relatively higher H3K4
dimethylation (Figure 3A). Interestingly, it was observed that
adipokine promoters in the grafted fat (VC or VT) acquired the
active (H3K4me2) marks after translocation to these peripheral
sites. Similar, albeit modest changes were measured in H3K9
methylation(Figure3B)atallthe4adipokinegenepromoterregions.
Methylation of histone tails is regulated by 2 broad classes of
enzymes; methyltransferases and histone demethylase
29. LSD1 is a
nuclear amine oxidase that uses oxygen as an electron acceptor
to reduce methylated lysine to form lysine. LSD1 demethylates
H3K4me2 and H3K4me1 leading to suppression of gene expression.
SuV39h1(alsoknownasKMT1a)isahistonemethyltransferasethat
is capable of methylating lysine 9 of histone 3 (H3K9) leading to
chromatincompactionandtranscriptionalrepression.Thus,recruit-
ment of either, or both of these enzymes at gene promoter regions
would indicate repression of gene expression. We carried out immu-
noprecipitation for LSD1 and KMT1a in visceral, thigh and chest fat
depots/graft. We measured changes in recruitment of these enzymes
to adipokine promoter regions. Interestingly, we observe that LSD1
and/or KMT1a were recruited at relatively much higher levels in
visceral fat (Figure 4). Surprisingly, translocation to peripheral sites
causedreductioninrecruitmentofLSD1and/orKMT1a(Figure4)at
these adipokine promoters.
Translocation of fat from visceral to peripheral sites offers
metabolic advantage. We then assessed the effects of autologous
fat transplantation on metabolism. We observe that translocation
of visceral fat to subcutaneous sites leads to increase in expression
of the brown adipose tissue uncoupling protein (UCP) 1
30 as well as
the mammalian analogs UCP2 and UCP3. This indicates improved
thermogenesis/heat energy metabolism due to fat transplantation.
Expression of RBP4 however did not change in the transplanted
tissue at 1 month after the surgery (Supplementary figure 5).
We measured circulating concentrations of adiponectin and
leptin, which are known to play an important role in the outcome
of metabolic disease. It is known that Adiponectin prevents
lipopolysaccharide (LPS/endotoxin) induced liver injury and that
obesity increases liver sensitivity to low doses of endotoxin,
quickly developing steatohepatitis. Our data indicates that animals
receiving subcutaneous transplant have improved levels of circulat-
ing adiponectin along with lower levels of serum endotoxin
(Figure 5A,C). Improvement in metabolic state was suggestive from
decline in circulating leptin concentrations after transplantation
(Figure 5B).
We then measured sensitivity to insulin in these animals at 1
month after transplantation by using hyperinsulinemic-euglycemic
clamps. Under steady state of euglycemia, glucose infusion rate
(GIR) equals glucose uptake by all the tissues in the body and clamp
studies are therefore considered as an ideal measure of insulin
sensitivity. GIR was significantly different (p , 0.001) between
pre-and post-transplant rats (Figure 5D,E). Post-transplant animals
showed 2.5-fold increase in GIR confirming that animals receiving
the subcutaneous fat transplant improved their glucose utilization
duringhyerinsulinemic-euglycemic clamp.(Figure5D,E).Tolerance
tests carried out (Supplementary figure 7) also confirm insulin sens-
itivity in these rats.
Glucose regulates epigenetic changes in adipose tissue. Our data
demonstrates that adipokine gene transcription in visceral adipose
tissue wasepigenetically repressed (Figures 3,4). Ittherefore became
intriguing to identify extrinsic factors that lead to repression of gene
expression. Oneofthemajorextrinsic factorsknowntobepresentat
high concentrations in the gut region, as compared to peripheral
sites, is glucose
26. There is now increasing evidence to believe
that this fundamental energy source can influence chromatin
conformation
31–33, gene expression
34,35 as well as other important
processes
36 including beta cell regeneration/proliferation
37.
We measured glucose concentrations at pre-hepatic and peri-
pheral sites at 30 minutes after oral glucose load. Glucose concen-
trations in the peripheral region are significantly lower (p#0.001)
than those in the gut region, before the first pass through liver
(Figure 6A,B). To assess effects of glucose on gene expression, we
cultured visceral fat explants for 72 hours in media containing lower
Figure 3 | Adipokine gene promoters in visceral fat acquire active marks
(H3K4 methylation) following translocation of visceral fat to peripheral
(thigh/chest) sites. Chromatin immunoprecipitation (ChIP) followed by
quantitativereal-timePCRwascarriedoutusingpromoter-specificprobe-
primersforeachadipokinepromoterregion.Dataarepresentedrelativeto
methylation at promoter region of visceral fat (V) isolated at time of
transplantation. We assessed H3K4 (A) and H3K9 (B) dimethylation as
active and inactive marks of gene expression respectively. Following fat
translocation to thigh (T) or chest (C) region, a significant increase in
H3K4 methylation was observed for almost all the adipokine gene
promoter regions.
www.nature.com/scientificreports
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lower glucose concentration induced 200 to 2000-fold increase in
transcript abundance of adiponectin, leptin, resistin and visfatin
genes (Figure 6C). Similarly, subcutaneous adipose tissue biopsy
slices cultured in high glucose concentrations demonstrated a
400- to 1500-fold suppression in gene expression (Supplementary
figure 6). These studies demonstrate that glucose alone can induce
changes in gene expression, thereby mimicking the results obtained
via subcutaneous transplantation/translocation. Although these
observations confirm the mechanism of regulation of gene express-
ion, we investigated if these effects of glucose conferred a ‘‘global’’
repression in gene expression. We carried out TaqMan low density
arrays using microfluidics cards that were custom printed for
selected genes involved in glucose-insulin metabolism. We observe
that although adipokines (Figure 2, Suppl. figure 4) and other key
genes involved in glucose-insulin metabolism were regulated to
match the level of gene expression in resident tissue (Figure 7A),
several other genes remained unaltered (Figure 7B). We identify
these genes as glucose responsive (Figure 7A) or glucose non-
respnsive (Figure 7B) genes and are presently carrying out further
studiestoidentify thetheirbiologicalprocesses, cellularcomponents
and molecular functions.
Discussion
Distribution of body fat is considered as an important predictor of
metabolic abnormalities in obese individuals. Adipose tissue is now
considered as an endocrine organ that secretes several inflammatory
and immune mediators including adiponectin, leptin, resistin and
visfatin. Subcutaneous thigh fat is inversely associated with glucose
and lipid concentrations, while increased visceral adiposity is inde-
pendently associated with insulin resistance, T2D, cardiovascular
disorders, inflammatory disorders and certain forms of cancers
through dysregulation of adipokine secretion. The site-specific dif-
ferences in visceral and peripheral fat depots is therefore important
in understanding the role of visceral adiposity as a causal factor for
metabolicdisease.Leptin,anadiposetissuederivedprotein,isknown
to be important in regulating energy intake, energy expenditure,
appetite and metabolism. Circulating concentrations of leptin are
proportionaltobodyfat.Adiponectinisa24 kDapolypeptide,which
mediates important metabolic processes such as glucose regulation
and fatty acid catabolism. Exclusively secreted from the adipose tis-
sue into the blood stream, its serum levels are inversely correlated
with body fat percentage in adults.
The aim of this investigation was to assess the fate of surgically
transplanted visceral fat following autologous transplantation. We
demonstrate that gene expression profiles of visceral adipose tissue
are influenced following translocation to peripheral sites. These
changes in gene expression are retained even at several weeks after
transplantation and involve modifications in chromatin conforma-
tion. It is increasingly appreciated that methyl groups at the histone
tails can be modified as a result of demethylation. Indeed, until
recently, it was believed that methyl groups could not be removed
from histones. However, recent studies characterize lysine-
specificdemethylase1(LSD1)andJumonjiC(JmjC)asH3demethy-
lases
38–40. LSD1 is a nuclear amine oxidase that uses oxygen as an
electron acceptor to reduce methylated lysine to lysine
41,42. LSD1
demethylatesH3K4me2andH3K4me1andisconsistentwithitsrole
in removal of the active methylation marks. LSD1 is found in co-
repressor complexes and promotes suppression of gene express-
ion
41,42. KMT1A (SuV39h1) has a conserved Set [Su(var)3–9,
Enhancer-of zeste, Trithorax] catalytic domain that belongs to the
histone methyl-transferase family and is capable of methylating
lysine 9 of histone H3 (H3K9) to mediate transcriptional repression.
Ourdatademonstratesthatdifferencesinadipokinegeneexpression
observed amongst all fat depots are epigenetically regulated via
recruitment of LSD1 and KMT1a at adipokine promoter regions.
We also demonstrate that recruitment of enzymes involved in his-
tone methylation is mediated via glucose and that these effects are
reversibleasin vitroexposure to lowglucose concentrations reverses
the repression in gene expression (Figure 6). Although we have
not assessed DNA methylation in this study, other studies suggest
positive correlation between glucose concentrations and DNA
methylation
34,35.
Brown adipose tissue (BAT) is also known to play an active role
in thermogenesis. BAT employs the uncoupling protein (UCP),
which is a membranous mitochondrial ion carrier
30. UCP, (also
Figure 4 | ChangesinadipokinepromotermethylationinvolverecruitmentofLSD1andKMT1a. LSD1andKMT1arecruitmentatpromoterregionsis
suggestive of gene repression (see text). Recruitment of LSD1 and KMT1a at adipokine gene promoter regions was assessed by carrying out chromatin
immunoprecipitation for the 2 enzymes. Either LSD1 and/or KMT1a abundance at adipokine promoters was seen to decrease significantly following
transplantation of visceral fat (V) to Thigh (VT) or chest (VC) region.
www.nature.com/scientificreports
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mitochondrialmatrix,producingheatandaconcomitantdecreasein
the ATP yield of oxidative phosphorylation. As a consequence,
oxidativemetabolismintheBATproceedsatamaximumrate,enab-
ling its mitochondria to produce more heat. Norepinephrine,
released from sympathetic nerves and acting via beta-adrenoceptors
and cAMP, is the main positive regulator of both UCP synthesis and
activity. BAT thermogenesis is thus known to play a critical role in
thermoregulation and in overall energy balance. Although we have
not directly measured heat production / oxygen consumption in
these animals post-translocation, our present findings direct us to
focus future studies on addressing these questions. Our findings
using in vivo translocation as well as in vitro fat explants represent
a paradigm shift in understanding the relationship between epige-
netic changes and hyperglycemic memory in the context of meta-
bolic disease. It becomes interesting to study the epigenetic effects of
elevated glucose concentrations on chromatin conformation, tran-
scription regulation and gene expression. In this regard, we are
involved in assessing clinical samples from 2 major studies concern-
ingindividualsthatprogressedtotype1diabetes(INIT-II)andthose
whoprogresstoinsulin-requiringtype2diabetesintheFIELDStudy
cohort. Future studies involving gene ontology analysis will help in
understanding the role of hyperglycemia on epigenetic suppression
of gene expression with reference to metabolic disease in human
populations. Although further studies need to be carried out
to understand the complex networks of glucose-regulated and
-independentgenes,thepresentstudydemonstratesforthefirsttime
the role of ‘‘residence factors’’, specifically glucose, in epigenetic
regulation of adipokine gene promoters to offer a metabolic benefit
following autologous fat transplantation.
Methods
Animals and surgical procedures. Wistar rats (Supplementary figure 1) were taken
for autologous fat transplantation studies as per the institutional approved ethics
protocol # EAF2007/B-100. Surgeries were carried out under isofluorane anesthesia
ina sterile operating theater fitted withHEPAfilters. Inpilot studies,visceraladipose
tissue was estimated at , 8 grams in each animal. Around 40% of visceral fat was
removed and 95% of this excised fat was implanted subcutaneously in the thigh or in
the chest region. Remaining 5% of the excised fat was frozen for analysis. Animals
were euthanized on day 4, day 21 or 1 month after surgery (n58/time point) and
transplanted adipose tissues and residual fat depots were retrieved. All surgical and
animal procedures are carried out as per the institutional guidelines for use of
laboratoryanimalsandasapprovedbytheEthicsCommitteeofNCCS.Animalswere
analyzedforassessmentofabdominalfatbyMRIscan(Siemens1.5Tesla)beforeand
Figure 5 | Autologous transplantation of fat offers metabolic advantage. To confirm any metabolic advantages offered as a result of autologous fat
transplantation procedure, we measured circulating concentrations of (A) adiponectin, (B) leptin and (C) endotoxin in serum of rats before (day 0) or
after (day 21) surgery. Hyperinsulinemic euglycemic clamps were carried out (D,E) to confirm that translocation of visceral fat to sub-cutaneous sites
offered improved insulin sensitivity in these rats. P,0.001, N55.
www.nature.com/scientificreports
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X-ray absorptiometry (pDEXAH Sabre ORTHOMETRIX, INC.).
Histology and immunochemistry. The residual fat tissue samples and grafted
visceralfatwasanalyzedbyconventionalhistochemicalanalysis.Tissueswerefixedin
10% formalin, embedded in paraffin and sectioned for hematoxilin and eosin (H&E)
staining. Representative sections from the same tissue blocks were immunostained
for anti-rat CD31 antibody (AbCam, USA) and nuclei (visualized by Hoechst33342)
before observation using LSM 510 Meta confocal microscope (Carl Zeiss GmbH,
Munich).
Assays.TaqManassays:Adiposetissuesamplesweresnapfrozenuponremovalusing
and stored at 280uC until further processing. All samples were thawed on ice and
homogenized using conventional battery operated handheld homogenizer. Tissue
lysates were solubilized in 1 ml of Tri reagent (Sigma, St. Louis, MO) and re-
suspended to ensure that all tissue lysates are solubilized. An oil layer (upper phase)
observed at this time was removed and samples were then processed as per the
manufacturer’s instructions. Total RNA was quantified on ND-1000
spectrophotometer (NanoDrop Technologies, Wilmington, DE) and reverse
transcribed to obtain cDNA using ‘High Capacity cDNA Reverse Transcription Kit’
(Applied Biosystems, Foster City, CA). Ten nanograms equivalent of cDNA was
taken for gene transcript analysis using validated Assay-on-demand TaqMan PCR
probe-primers (LifeTechnologies, Carlsbad, CA). Fold-changes werecalculated after
normalization for 18S rRNA using 2
2DD Ct method as described earlier
43. Gene
transcript analysis was then carried out using 7500 FAST or 7900 HT real-time PCR
system(LifeTechnologies,Carlsbad,CA).Forsimultaneousassessmentofanarrayof
genes using TaqMan chemistry, we custom printed microfluidics cards (TLDAs;
TaqManLowDensityArrays)usinganinventoriedsetofgeneexpressionassaysfrom
Applied Biosystems (Life Technologies, Carlsbad, CA).
Chromatin Immunoprecipitaion (ChIP) assays: Residual adipose tissues and/or grafts
were taken for ChIP using a slight modification of existing protocols
44,45. Briefly,
adipose tissue was finely chopped, cross-linked using 1% formaldehyde (Sigma, St.
Louis, MO) and sonicated to generate 300 bp to 1.2 kb DNA fragments. Quality and
quantity of chromatin was assessed and immunoprecipitation using 2 mg of specific
dimethyl antibodies for H3K4 and H3K9 (Millipore, Billerica, MA) was carried out.
Precipitation cocktail include protein A/G plus beads (Pierce, Pittsburgh, PA),
sonicated salmon sperm DNA (Amersham Biosciences Pittsburgh, PA) and BSA
(Sigma, St. Louis, MO). Rabbit IgG (Upstate, Millipore, Billerica, MA) is used as
isotype control. Chromatin was eluted using 2%SDS, 0.1 M NaHCO3 and 10 mM
DTT. Cross-links are reversed by incubating the eluted chromatin in 4 M NaCl for
4 hours at 65uC. This is followed by proteinase-K digestion. DNA is then extracted
using phenol-chloroform- isoamyl alcoholfollowedbyprecipitation and twowashes
of 70% ethanol and finally dissolved in nuclease-free water. The online Ensembl
database was used (http://www.ensembl.org) to select 1 kb region upstream of
1
st exon for designing promoter specific primers and using online primer designing
tool (http://www.idtdna.com/Scitools/Applications/Primerquest/) (Supplementary
table 1). These primers were used to carry out real time PCR on input, immuno-
precipitated and isotype control DNA. All real time PCR results were normalized to
GAPDH promoter (Active/positive control)/intergenic region and carried out in
duplicate and presented as fold-chage as compared to Gapdh promoter.
Hyperinsulinemic-euglycemic clamps and tolerance tests: All clamp studies were car-
ried out as described earlier
46,47. Briefly, rats are fasted for 10 hours and catheterized
afterbeinganesthetized withisoflurane.Theleftcommoncarotidarteryandtheright
jugularveinarecatheterizedforsampling.Thefreecatheterendfromcarotidarteryis
used to collect 50 ml blood per 10 min. The free catheter end from the jugular vein is
used to infuse insulin and glucose. The insulin clamp begins at 0 min with a primed-
continuous infusion of human insulin 300 mU/kg bolus followed by 4 mU/kg/min.
Normoglycemia (80–110 mg/dl) is maintained during clamps by measuring blood
glucose every 5–10 min starting at 0 min and infusing 10% dextrose as necessary.
Blood samples were taken every 10 min for 120 min and processed to determine
insulin. For insulin tolerance test, rats were fasted overnight and injected intraper-
itoneally with 1 unit/kg (Actrapid; Novo Nordisk, Denmark). Glucose concentra-
tions were measured before insulin injections and at every 30 minutes for 2 hours.
For glucose tolerance test, overnight fasted rats were injected with 2 g/kg glucose
(intraperitoneally) and glucose concentrations were measured before and at every
30 minutes after glucose injection for next 2 hours.
Blood Sampling and Chromogenic LAL (Limulus Amoebocyte Lysate) assay: Fasting
blood samples were collected in sterile tubes by retro-orbital bleeding under iso-
fluorane anaesthesia. The LAL assay (Lonza Biosciences-QCL 1000 kit) is used for
Figure 6 | Glucosealonecaninduceincreaseinadipokinegeneexpression. Bloodglucosemeasurementsweresimultaneouslycarriedoutat30 minutes
after oral glucose was administered (A). We observe that local concentration of glucose in portal circulation are higher before first pass through liver,
N56=,7R(B). Ratsgenerally eat throughout theday/night andvisceral adipose tissue isthereforeexposedtohighconcentrations ofglucose ascompared
toperipheraladiposetissue.Totesttheroleofglucose,weharvestedvisceralfatfromadultratsandexposedittolowglucoseconditionsfor72 hours(C).
Following exposure to low glucose conditions, adiponectin, leptin, resistin and visfatin mRNA increased by at least 200-fold as compared to the
abundance of these transcripts in the harvested (day 0) visceral tissue (N54 rats).
www.nature.com/scientificreports
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0.1 EU/ml to 1.0 EU/ml. All samples were collected in double autoclaved nuclease-
free 1.7 ml tubes to avoid microbiological or endotoxin contamination.
Serum leptin and adiponectin assay: Serum samples were processed for assessing
leptin and adiponectin using ELISAs (Millipore Corporation, Billerica, MA) as per
the manufacturer’s protocol.
In vitro culture of adipose tissue explants: Visceral adipose tissue explants were pre-
pared by slicing visceral adipose tissue with a sterile surgical scalpelblade. Slices were
usually around 0.5 to 1 mm in thickness. Explants were washed twice with fresh
DME/HF12 media before culture in tissue-culture treated 24-well plates and pro-
cessed for RNA isolation and cDNA preparation at 72 hours of exposure to low
glucose conditions. Explants that were cultured in high glucose concentrations
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